Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay (Q39413554)

11 September 2017

Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay (English)

1 reference

11 September 2017

0 references

Joseph N Jarvis

5

0 references

author name string

Joan Rugemalila

1

1 reference

11 September 2017

Venance P Maro

2

1 reference

11 September 2017

Gibson Kapanda

3

1 reference

11 September 2017

Arnold J Ndaro

4

1 reference

11 September 2017

1 September 2013

1 reference

Tropical Medicine and International Health

11 September 2017

1 reference

11 September 2017

18

1 reference

11 September 2017

9

1 reference

11 September 2017

1075-1079

1 reference

Comparison of four assays for the detection of cryptococcal antigen

11 September 2017

1 reference

Serotype sensitivity of a lateral flow immunoassay for cryptococcal antigen

21 January 2018

1 reference

Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid

21 January 2018

1 reference

HIV-associated cryptococcal meningitis.

21 January 2018

1 reference

Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa

21 January 2018

1 reference

Cryptococcal antigen screening for patients initiating antiretroviral therapy: time for action

21 January 2018

1 reference

Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis

21 January 2018

1 reference

Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation

21 January 2018

1 reference

Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa

21 January 2018

1 reference

Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania

21 January 2018

1 reference

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

21 January 2018

1 reference

Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda

21 January 2018

1 reference

Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis

21 January 2018

1 reference

Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory.

21 January 2018

1 reference

Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings

21 January 2018

1 reference

The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya

21 January 2018

1 reference

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

21 January 2018

1 reference

Systematic screening of cryptococcal antigenemia in HIV-positive adults in Uganda

21 January 2018

1 reference

Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study

21 January 2018

1 reference

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe

21 January 2018

1 reference

Cryptococcal infection in an HIV-positive Ugandan population

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TMI.12157

1 reference

11 September 2017

1 reference